Injective (INJ) rallied sharply on October 16, gaining 27% to trade near $9.20, marking its highest price since October 2025. The move positioned the altcoin as the day's top performer across major digital assets and pushed its market capitalization above $920 million.
Regulatory Catalyst
The primary driver behind the surge appears to be a meeting in Washington between Injective CEO Eric Chen and officials from the White House, SEC, and CFTC. According to Injective, the delegation included the project's General Counsel, Head of Policy, and Head of Research. The project stated it has "quietly built the foundation for tokenization to thrive in America, inside the regulatory framework and in direct collaboration with the U.S. government and major regulatory bodies."
Additional Developments
CoinGecko identified other potential catalysts supporting the rally, including a community vote on proposal IIP-709 regarding fixed gas fees. Injective also highlighted that its revenue-to-FDV ratio has exceeded that of other major blockchain networks.
Technical Analysis
Analysts noted technical formations suggesting additional upside potential. One analyst observed that INJ broke above a cup-and-handle pattern and had gained 30%, with the pattern projecting a potential target near $14. Other observers cited historical chart patterns as supportive of further strength.
Overbought Signals
Technical indicators suggest caution in the near term. INJ's Relative Strength Index (RSI) climbed to nearly 80, a level typically associated with overbought conditions that can precede corrections. RSI readings above 70 historically signal potential pullbacks. Observers noted that after the strong move, some volatility around the $9 support level could occur in the coming days.
